Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qizhi Weitong Tablets is a Traditional Chinese Medicine (TCM) formulation used to treat gastrointestinal disorders characterized by "Qi stagnation," such as functional dyspepsia and epigastric pain. The formula typically comprises several botanical ingredients, including *Radix Bupleuri* (Chaihu), *Rhizoma Cyperi* (Xiangfu), *Fructus Aurantii* (Zhiqiao), *Rhizoma Corydalis* (Yanhuosuo), *Radix Paeoniae Alba* (Baishao), and *Radix Glycyrrhizae* (Gancao). It is designed to soothe the liver, regulate Qi, and alleviate pain by harmonizing the relationship between the liver and the stomach. Clinical research, including studies sponsored by Wangjing Hospital of the China Academy of Chinese Medical Sciences, has evaluated the drug's efficacy in treating functional dyspepsia (specifically epigastric pain syndrome) accompanied by anxiety, suggesting a multi-target mechanism that modulates the brain-gut axis to improve both physical gastric symptoms and psychological distress.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on qizhi weitong tablets.